+ T cells. These data suggest that the developmental pathway of Tfh cells differs between mice and humans, which have considerable implications for vaccine development.
INTRODUCTION
DCs sense microbial invasion and mobilize immune system effectors (Banchereau and Steinman, 1998; Pulendran et al., 2008; Reis e Sousa, 2004; Shortman and Liu, 2002) . Upon recognition of signals derived from the innate immune system and/or microbial components, DCs migrate to secondary lymphoid organs, i.e., spleen and lymph nodes, where they mature and launch adaptive immunity. In particular, DC subsets play a central role in the induction of distinct subsets of T cells (Klechevsky et al., 2008; Ueno et al., 2007) , which produce different sets of cytokines necessary to clear distinct types of microbes. T helper 1 (Th1) cells secrete interferon-g (IFN-g), which allows for the control of intracellular microbes, Th2 cells secrete interleukin-4 (IL-4), which mediates immunity against extracellular parasites (Mosmann and Coffman, 1989) , and Th17 cells secrete IL-17A and IL-22, which control extracellular bacteria Ouyang et al., 2008) . DCs produce soluble factors or express cell surface molecules that regulate the fate of T cells. For example, IL-12-secreting DCs potently promote the development of Th1 cells (Trinchieri, 2003) . On the contrary, DCs lacking IL-12 secretion (Langenkamp et al., 2000; Pulendran et al., 2001) , particularly those expressing OX40 ligand (Ito et al., 2005) , promote Th2 responses.
Recently, a subset of CD4 + T cells, T follicular helper (Tfh) cells, originally found in germinal centers (GCs) of secondary lymphoid organs (Breitfeld et al., 2000; Campbell et al., 2001; Kim et al., 2001; Schaerli et al., 2000) , has been established as a critical cell compartment specialized for the help of B cell responses (Fazilleau et al., 2009; King et al., 2008; Vinuesa et al., 2005) . Tfh cells express chemokine (C-X-C motif) receptor 5 (CXCR5) and migrate into B cell follicle in response to its ligand, CXCL13, which is produced by follicular DCs (Cyster et al., 2000; Gunn et al., 1998) . Together with activated B cells and follicular DCs, Tfh cells constitute germinal centers (GC), where B cells undergo isotype switching and somatic hypermutation. This step permits the selection of high-affinity B cells in GCs and leads to the generation of B cell memory (Allen et al., 2007; MacLennan, 1994) . Tfh cells provide help to B cells through several factors, including CD40 ligand (CD40L) (Banchereau et al., 1994) and ICOS (Hutloff et al., 1999) . In particular, Tfh cells secrete the cytokine IL-21 (Bryant et al., 2007) , which drives the growth, differentiation, and isotype switching of B cells (Kuchen et al., 2007; Spolski and Leonard, 2008) . Furthermore, substantial evidence shows that Tfh cells at extrafollicular sites also help B cell differentiation into plasma cells in an IL-21-dependent fashion Odegard et al., 2008) . However, the mechanism whereby human DCs induce such IL-21-producing Tfh cells is unknown. IL-21 itself provides a positive feedback loop to CD4 + T cells and induces human (Caprioli et al., 2008) and mouse Nurieva et al., 2007; Suto et al., 2008; Vogelzang et al., 2008; Wei et al., 2007) naive CD4 + T cells to secrete more IL-21.
The critical involvement of IL-21 for the induction of Tfh cells in vivo was recently demonstrated in mouse model (Nurieva et al., 2008; Vogelzang et al., 2008) . However, antigen-presenting cells (APCs) including DCs or naive CD4 + T cells do not secrete IL-21, therefore raising the question about the mechanism whereby APCs trigger the differentiation of IL-21-producing CD4 + T cells.
Recently, IL-6 has been shown to induce mouse CD4 + T cells to secrete IL-21 (Dienz et al., 2009; Zhou et al., 2007) , but whether human CD4 + T cells share the same pathway is unknown.
In this study, we demonstrate that human DCs instruct naive CD4 + T cells to become IL-21-producing Tfh-like cells through the secretion of IL-12, thus revealing another substantial difference in the immune systems of mice and humans (Mestas and Hughes, 2004) . The nomenclature of ''Tfh-like'' cells is discussed later.
RESULTS

Activated DCs Induce Naive CD4 + T Cells to Produce IL-21
We first examined whether human DCs were able to induce naive CD4 + T cells to differentiate into CD4 + T cells secreting IL-21.
DCs were generated by culturing monocytes with GM-CSF and IL-4 for 6 days, and activated for 6 hr with LPS or CD40L-transfected L cells. DCs were subsequently cultured (1.3 3 10 3 cells/well) with allogeneic naive CD4 + T cells (4 3 10 4 cells/ well). At day 7, CD4 + T cells were restimulated with PMA and ionomycin for 6 hr in the presence of brefeldin A to assess intracytoplasmic IL-21 expression. Very low amounts of intracytoplasmic IL-21 were detected in a small fraction of CD4 + T cells primed with resting DCs ( Figure 1A ; 4.7% ± 2.7% of activated CD4 + T cells; mean ± SEM; n = 3). In contrast, DCs exposed to LPS or CD40L induced a larger fraction of CD4 + T cells to express IL-21 ( Figure 1A ; 14.8% ± 1.6% and 22.5% ± 0.8% of activated CD4 + T cells, respectively; mean ± SEM; n = 3). Note that the expression of IL-21 was much higher on T cells that have been primed with activated DCs than in T cells primed with immature DCs ( Figure 1A) . Accordingly, CD4
+ T cells primed Figure 1C ). The degree of induction varied with the DC activation signal. CD40L-activated DCs were the most potent (IL-21: 3020 ± 970 pg/ml from 5 3 10 4 cells; mean ± SD; n = 3). LPS was the most potent TLR-ligand (470 ± 120 pg/ml), followed by flagellin (190 ± 21 pg/ml) and CL097 (110 ± 14 pg/ml). Supernatants from DCs activated with PGN were poor at developing IL-21-producing CD4 + T cells (26 ± 2 pg/ml). plate-bound anti-CD3 + anti-CD28 in the presence of cytokines (10 ng/ml, except IFN-a at 500 IU/ml) known to be produced by DCs (de Saint-Vis et al., 1998) . IL-1b, IL-6, IL-10, IL-18, IL-27, TNF-a, and IFN-a did not induce CD4 + T cells able to express ( Figure 1D ) or secrete IL-21 ( Figure 1E ). However, IL-12 and to a minor extent IL-23 promoted the development of CD4 + T cells able to produce IL-21. Upon reactivation through CD3 + CD28, CD4 + T cells primed with IL-12 were able to secrete nanogram amounts of IL-21 (3.3 ± 0.4 ng/ml in a culture of 5 3 10 4 cells/200 ml; mean ± SEM; n = 5), whereas those primed with IL-23 secreted only picogram amounts (40 ± 4 pg/ml, mean ± SEM; n = 5; Figure 1F ). IL-27, another IL-12 family cytokine, did not promote any IL-21 production. As reported earlier (Caprioli et al., 2008) , IL-21 induced naive CD4 + T cells to secrete IL-21 at some extent, though when compared to IL-12, the effect was marginal at all examined concentrations (10-100 ng/ml) ( Figure 1G ). Of note, IL-12 also induced IL-21-producing CD4 + T cells in cultures with serum-free medium (X-VIVO15, data not shown), indicating that the induction of IL-21-producing CD4 + T cells by IL-12 does not require serum components. Titration studies revealed that as little as 1 pg/ml of IL-12 allowed the generation of T cells capable of secreting measurable amounts of IL-21 (Figure 2A ). In contrast, much larger amounts of IL-23 were required to induce CD4 + T cells capable of producing measurable amounts of IL-21. IL-21 or IL-23 did not act in synergy with IL-12, as shown by the fact that neither cytokines enhanced IL-21 secretion by CD4 + T cells primed with suboptimal IL-12 (100 pg/ml; Figure S1 available online).
Thus, IL-12 potently induces the development of IL-21-producing CD4 + T cells.
IL-12 Induces Two Different Types of IL-21-Producing CD4 + T Cells
IL-12 is a potent inducer of Th1 cells (Trinchieri, 2003) and accordingly induced naive CD4 + T cells to secrete IFN-g ( Figure 2A ). Indeed, 73% ± 2% of IL-21-positive CD4 + T cells induced by IL-12 (10 ng/ml) coexpressed IFN-g (mean ± SEM; n = 6; Figure 2B ). However, IL-12 also promoted in a dosedependent manner the development of IL-21-expressing CD4 + T cells that lacked IFN-g expression ( Figure 2C ). Importantly, IL-12 induced both IFN-g + IL-21 + and IFN-g À IL-21 + cells from highly purified cord blood naive CD4 + T cells ( Figure 2D ). To determine the commitment to the Th1 pathway, the expression of T-bet, a Th1-associated transcriptional factor, was analyzed. to secrete Igs, including IgM (2.7 ± 0.5 mg/ml, mean ± SEM; n = 6), IgG (0.32 ± 0.08 mg/ml), and IgA (0.19 ± 0.04 mg/ml). Naive B cells cocultured with CD4 + T cells primed with IL-23 produced much lower amounts of Igs (IgM, 0.02 ± 0.02 mg/ml; IgG, 0.02 ± 0.02 mg/ml; IgA, 0.02 ± 0.01 mg/ml; mean ± SEM; n = 6). Figure 3B ; IL-12: IgM 31.9 ± 3.7 mg/ml, IgG 23.0 ± 1.7 mg/ml, IgA 10.8 ± 2.6 mg/ml; IL-23: IgM 2.3 ± 1.6 mg/ml, IgG 4.5 ± 1.7 mg/ml, IgA 0.9 ± 0.3 mg/ml; mean ± SEM; n = 6). 
(F) Expression of T-bet and intracytoplasmic cytokines was analyzed in tonsillar CD4 + T cells stimulated with PMA + ionomycin.
(G) Naive CD4 + T cells were cultured for 7 days with CD3 + CD28 mAbs under Th0, Th1, Th2, or Th17-skewing conditions. IL-21 secretion upon 24 hr CD3 + CD28
restimulation from activated CD4 + T cells. Mean ± SD. Figure 4A ). DCs stimulated with S. aureus or P. gingivalis were also able to induce IL-21 production by CD4 + T cells though less potently than did E. coli-activated DCs. Indeed, E. coli-activated DCs secreted far more IL-12p70 and IL-23 than did S. aureus and P. gingivalis-activated DCs ( Figure 4B ). Addition of IL-12p40-blocking mAb, which inhibits both IL-12 and IL-23, to the cocultures of E. coli-activated DCs and T cells inhibited IL-21 secretion by CD4 + T cells ( Figure 4C) . Notably, addition of IL-12p70-blocking mAb, which inhibits IL-12 alone, was sufficient to inhibit IL-21 secretion (85% ± 5% inhibition by IL-12p70 blocking; mean ± SEM; n = 5).
Blocking of IFN-a, IFN-g, IL-1b, or TNF-a did not inhibit IL-21 secretion ( Figure S8 ). IL-12p70 blocking also resulted in a substantial decrease of IL-21 secretion by CD4 + T cells stimulated with DCs exposed to S. aureus (87% ± 3% decrease, n = 4) or P. gingivalis (80% ± 9% decrease, n = 4). Overall, anti-IL-12p40 Immunity IL-12 Regulates IL-21 Production by CD4 + T Cells and anti-IL-12p70 were equally potent at inhibiting the induction of IL-21-producing CD4 + T cells ( Figure S9 ). These results indicate that the induction of IL-21 producers by bacteria-activated DCs was mainly mediated by IL-12. This pathway was also shared by DCs stimulated with CD40L and LPS ( Figure 4D ). As expected, CD40L-stimulated DCs, whose supernatant induced naive CD4 + T cells to secrete the highest amounts of IL-21 (Figure 1C) , produced the largest amount of IL-12p70 ( Figure 4E) . 
IL-12 Increases the Secretion of IL-21 by Memory CD4 + T Cells
We next determined whether IL-12 also controls IL-21 secretion by memory CD4 + T cells. Fresh PBMCs from healthy adults produced high amounts of IL-21 when cultured with SEB for 48 hr (740 ± 250 pg/ml; mean ± SEM; n = 7; Figures 5A and 5B). Blocking IL-12p70 during the 48 hr activation period resulted in a significant decrease of IL-21 secretion (110 ± 30 pg/ml; n = 7; p < 0.05; Figure 5B ). Blocking of both IL-12 and IL-23 with anti-IL-12p40 decreased IL-21 secretion (120 ± 40 pg/ml; n = 6) to a degree comparable to blocking IL-12 alone. The secretion of IFN-g was also strongly inhibited with anti-IL-12p70, but blocking IL-12 did not alter the secretion of other cytokines including IL-2, IL-5, and IL-17A ( Figure 5B ). Thus, blocking IL-12 specifically inhibited the secretion of both IL-21 and IFN-g. To further confirm the IL-12-dependent induction of IL-21 secretion by memory CD4 + T cells, memory CD4 + T cells were sorted and stimulated with anti-CD3 + anti-CD28 in the presence of IL-12, IL-23, and IL-27. As shown in Figure 5C , IL-12 potently induced memory CD4 + T cells to secrete IL-21 between 24 and 48 hr after stimulation, indicating the delayed mode of action. Naive CD4 + T cells did not secrete detectable amounts of IL-21 during the first 72 hr ( Figure 5D ). These observations indicate that IL-12 directly acts on memory CD4 + T cells and promotes the secretion of IL-21.
Induction of IL-21 Producers by IL-12
Is Dependent on STAT4 IL-12 activates multiple signal transduction pathways, including signal transducer and activator of transcription 3 (STAT3) and STAT4 (reviewed in Watford et al., 2004) . Induction of IFN-g in CD4 + T cells by IL-12 is largely dependent on the activation of STAT4 (Kaplan et al., 1996; Thierfelder et al., 1996) . To determine the contribution of STAT3 and STAT4 for the induction of IL-21, STAT3 and STAT4 were targeted in naive CD4 + T cells by transfecting siRNA. siRNA transfection of naive CD4 + T cells stimulated with anti-CD3 + anti-CD28 mAbs for 5-7 days resulted in a decrease of the expression of STAT3 and STAT4 by approximately 60% at 24 hr after transfection ( Figure 6A ). Transfected Figure 6B ). In contrast, the induction of IL-21 producers in response to IL-21 was largely dependent on STAT3, an observation consistent with previous studies performed with mouse (Nurieva et al., 2008; Wei et al., 2007; Zhou et al., 2007) and human (Caprioli et al., 2008 ) CD4 + T cells. Furthermore, IL-23 also induced IL-21 producers in a STAT3-dependent manner.
The induction of IL-21-expressing CD4 + T cells was further analyzed by intracytoplasmic cytokine staining after 6 hr restimulation with PMA and ionomycin. As expected, STAT4 blocking inhibited the development of IFN-g-expressing CD4 + T cells in response to IL-12 ( Figure 6C ; 68% ± 5% with control versus 54% ± 5% with STAT4 blocking; mean ± SEM; n = 3; p < 0.005). Consistent with the analysis of IL-21 production, the development of IL-21-expressing CD4 + T cells by IL-12 was largely dependent on STAT4 ( Figures 6C and 6D) . Immunity IL-12 Regulates IL-21 Production by CD4 + T Cells with STAT4 blocking; mean ± SEM; n = 3; p < 0.001; IFN-g À IL-21 + : 7.3% ± 0.2% with control versus 3.8% ± 0.2% with STAT4 blocking; p < 0.01). STAT3 blocking only marginally decreased the generation of IL-21-expressing CD4 + T cells by IL-12 ( Figure 6D ). In contrast, the development of IL-21-expressing CD4 + T cells by IL-23 and IL-21 was confirmed to be dependent on STAT3, but not on STAT4 (Figures 6C and 6D) . Thus, the development of human IL-21-producing CD4 + T cells by IL-12 is largely dependent on STAT4. The definition of Tfh cells still remains controversial. As the name indicates, Tfh cells are generally defined by their location in vivo, i.e., at the follicular sites of secondary lymphoid organs. However, in a similar concept applied to other Th subsets, Tfh cells are also defined by their exclusive functions: i.e., the secretion of IL-21 and the function to help B cells through IL-21, rather than by their location. This function-based nomenclature fits well with a recent view of Tfh ''subsets,'' where Tfh cells are derived from different Th lineages and differently regulate B cell immunity (Fazilleau et al., 2009) . Furthermore, an increasing number of studies indicates that IL-21-producing ''extrafollicular'' Tfh cells Odegard et al., 2008) and pre-GC Tfh cells (Fazilleau et al., 2009) as S. aureus and P. gingivalis) were poor activators, which is consistent with their poor ability to induce DCs to produce IL-12 (Gerosa et al., 2008; Pulendran et al., 2001 (Cosmi et al., 2008) . (Dienz et al., 2009; Suto et al., 2008; Wei et al., 2007) . In mice, IL-6 and IL-21 have been reported as critical factors in the generation of IL-21-producing CD4 + T cells both in vitro and in vivo (Dienz et al., 2009; Korn et al., 2007; Nurieva et al., 2007; Suto et al., 2008; Zhou et al., 2007) . Because both IL-6 and IL-21 signal through STAT3, it has been concluded that STAT3 is critical in the generation of IL-21-producing CD4 + T cells. Indeed, STAT3-deficient mice severely impaired the development of Tfh cells (Nurieva et al., 2008; Wei et al., 2007) . Thus, the distinct mechanism in the development of IL-21-producing CD4 + T cells adds to the list of differences between the human and mouse immune systems (Mestas and Hughes, 2004) . Taken together, our results indicate that IL-12, which activates cellular immunity by inducing Th1 cells, also contributes to humoral immunity indirectly through the generation of Tfh cells. Actually, IL-12 from activated DCs also acts directly on activated naive B cells together with IL-6 to induce their differentiation into plasma cells (Dubois et al., 1998) . Therefore, when DCs form the ''mé nage à trois'' complex with antigen-specific T cells and B cells (Qi et al., 2006) (Hirao et al., 2008; Schadeck et al., 2006; van der Meide et al., 2002) . In contrast, blocking of IL-12 might be beneficial to prevent the development of autoreactive B cells in autoimmune diseases.
DISCUSSION
EXPERIMENTAL PROCEDURES
Isolation of CD4 + T Cells and B Cells
The study was approved by the Institutional Review Board of Baylor Health Care System. Informed consent was obtained from healthy subjects for the collection of blood apheresis samples. 
Coculture of DCs and Naive CD4 + T Cells
Monocytes were isolated from PBMCs with Monocyte Isolation Kit II (Miltenyi). DCs were generated by culturing monocytes with 50 ng/ml IL-4 (R&D) and 100 ng/ml GM-CSF (Leukine) At day 6, DCs were stimulated with irradiated CD40L-transfected L cells, PGN (5 mg/ml), LPS (50 ng/ml), flagellin (20 ng/ml), CL097 (imidazoquinoline compound; 5 mg/ml), heat killed-Escherichia coli (10 8 /ml), heat killed-Staphylococcus aureus (10 8 /ml, InvivoGen), or heat killed-Porphyromonas gingivalis (10 8 /ml, InvivoGen). After 6 hr stimulation, DCs were harvested and carefully washed; DCs stimulated with CD40L-transfected L cells were sorted as CD11c + CD40L À DCs. Activated DCs (1.3 3 10 3 cells/well) were cultured for 7 days with allogeneic naive CD4 + T cells (4 3 10 4 cells/well) in RPMI complete medium. In some experiments, 10 mg/ml anti-IL12p40 (C8.6) or anti-IL-12p70 (M122) blocking mAbs were added to the culture. For the assessment of IL-12 secretion, DCs harvested at 6 hr stimulation were cultured for another 24 hr in flat-bottom 96-well plates (2 3 10 5 cells/ well), and the secreted IL-12p70 and IL-23 were measured in triplicate cultures by ELISA (eBiosciences).
Stimulation of Naive CD4 + T Cells via CD3 and CD28
Naive or memory CD4 + T cells (1 3 10 5 cells/well) were stimulated with platebound CD3 mAb (5 mg /ml, OKT3) and soluble CD28 mAb (1 mg/ml, CD28.2) in flat-bottom 96-well plates in RPMI complete medium in the presence of IL-1b, IL-4, IL-6, IL-10, IL-12, IL-18, IL-27, and TNF-a (R&D), IL-21 (BioSource), IL-23 (eBiosciences) (10 ng/ml each or at indicated concentration), or IFN-a (IFN-a2b. 500 IU/ml. Schering). In some experiments, anti-IL-4 (MP4-25D2) or anti-IL-12p70 mAbs (2 mg/ml) were added to the culture.
Intracellular Staining
Naive CD4 + T cells stimulated for 7-9 days were restimulated with PMA (25 ng/ ml) and ionomycin (1 mg/ml) for 6 hr in the presence of GolgiPlug (BD) for the last 4 hr. Cells were then fixed and permeabilized and the expressed cytokines in the cytoplasm were analyzed with IL-21 PE or A647 (3A3-N2), IL-17A PE (64DEC17), TNF-a APC (MAb11), and IFN-g APC (B27) mAbs. For T-bet staining, cells were fixed/permeabilized with the Foxp3 Staining Buffer Set (eBiosciences) and stained with T-bet A488 (4B10), IL-21 PE, and IFN-g APC antibodies. In some experiments, dead cells were further excluded from the analysis by labeling with cells LIVE/DEAD After 24 hr, the levels of produced cytokines were assessed in triplicate cultures by Luminex.
Coculture of T and B Cells
Activated CD4 + T cells were cocultured with autologous naive or memory B cells (4 3 10 4 cells/well each) in 96-well round-bottom plates in Yssel medium/10% FBS in the presence of endotoxin-reduced SEB (0.25 ng/ml). Naive B cells were preactivated for 2 hr with 1 mg/ml rabbit anti-human IgM (Irvine Scientific), and CpG type B (0.5 mg/ml, ODN2006, InvivoGen) was added to the culture. In some experiments, ICOS-L-mIgFc (Ancell), IgG1Fc, or IL-21R/Fc (R&D) were added to the culture. Igs (IgM, IgG, and IgA) produced in the cultures were analyzed by ELISA at day 6 or 14.
siRNA Transfection Naive CD4 + T cells stimulated with CD3 + CD28 mAbs for 5-7 days were transfected with siRNA with the Human T cell Nucleofector Kit and Nucleofector II device (Amaxa). siRNA to target STAT3 (s743), STAT4 (s13531), and silencer select negative control #1 siRNA (Ambion) were used at 5 nM (0.5 nmol/5 3 10 6 cells/transfection). Cells were transferred at 6 hr after transfection to the wells with CD3 + CD28 Abs. Cytokines (IL-12 [10 ng/ml], IL-23 [10 ng/ml], or IL-21 [50 ng/ml]) were added to the culture 24 hr after transfection, and the cytokine expression was analyzed 48 hr later.
STAT3 and STAT4 Staining
The expression of STAT3 and STAT4 was assessed 24 hr after siRNA transfection. After labeling with LIVE/DEAD fixable Aqua, cells were incubated with BD cytofix buffer (BD) and then permeabilized with BD Phosflow Perm Buffer III (BD). Cells were then incubated with anti-STAT3 APC (BD) and anti-STAT4 (Zymed) Abs, followed by incubation with goat anti-rabbit IgG FITC.
Statistics
The significance of the difference between groups in the experiments was evaluated by two-tailed unpaired or paired t test. A value of p < 0.05 was considered significant.
Development of Human IL-21 Bead-Based Assay via Luminex Technology
See Supplemental Data.
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